Logo Helmholtz Zentrum München

Diabetes and Metabolic Diseases

Diabetes is one of the most prevalent common diseases in Germany and estimations of the United Nations have clearly defined it as a global threat to humanity. With its complex appearance due to various genetic and environmental factors involved new research approaches need to be established to develop individualized prediction, prevention and treatment in people and patients. Interdisciplinary and translational research projects are enabled through joint efforts of the Helmholtz Diabetes Center and the Alberta Diabetes Institute each focusing on different aspects of development, progression and therapy of diabetes and its various secondary diseases.

We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Only cookies permitted that are required for the basic functionality of our websites.
Permit cookies that help us to analyse the page views and user behavior on our websites. We only use this information for improving our services.
Permit embedded content and cookies from third party providers. This setting enables the full use of our web services (e.g. displaying videos).
Please find more information in our privacy statement.

There you may also change your settings later.